anti-CD70 CAR T-cell therapy linked with modified IL-8 receptor (University of Florida)

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug Nameanti-CD70 CAR T-cell therapy linked with modified IL-8 receptor (University of Florida)
Drug Alias Name8R-70CAR T cellsmodified IL-8 receptor-CD70 CAR T Cell therapy (University of Florida)modified IL-8 receptor linked with anti-CD70 CAR T-cell therapy (University of Florida)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCD70 antigen modulators
TargetsCD70 antigen
Therapy Area/IndicationsBrain metastasesOvarian NeoplasmsPancreatic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsBrain metastasesOvarian NeoplasmsPancreatic Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A